General Information of the Compound
| Compound ID |
CP0383443
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-bromo-4-N-(5-propan-2-yl-1H-pyrazol-3-yl)-2-N-(pyridin-3-ylmethyl)pyrimidine-2,4-diamine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H18BrN7
|
||||||||||||||||||
| Molecular Weight |
388.273
|
||||||||||||||||||
| Canonical SMILES |
CC(C)c1cc(Nc2nc(NCc3cccnc3)ncc2Br)[nH]n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H18BrN7/c1-10(2)13-6-14(24-23-13)21-15-12(17)9-20-16(22-15)19-8-11-4-3-5-18-7-11/h3-7,9-10H,8H2,1-2H3,(H3,19,20,21,22,23,24)
Show/Hide
|
||||||||||||||||||
| InChIKey |
JNSMYVIVQDWCFM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01091, Fibroblast growth factor receptor 1
Protein ID: PT01104, Insulin-like growth factor 1 receptor
Protein ID: PT00864, Vascular endothelial growth factor receptor 2